05/05/2020 21:08

$Qualigen Therapeutics Inc Here are some facts on why you should think about investing at this discounted price!!

1. Increase in cash by 4.3M reported ending March 31st, compared to December 31st.

2. $0.05 loss per share ending March 31st, compared to $0.58 December 31st.

3. Will be starting commercialization and monetization on RP-G28 Lactose Intolerance Drug after very promising results from the Phase 2b study.

4. FDA approval expected very shortly. They wouldn’t plan for monetizing unless they have high expectations for approval.

5. Qualigen merger going to be approved which add a huge partnership and bigger opportunities down the road.
Disclaimer: The comments, opinions and analysis expressed herein are for informational and educational purposes only and shoulk not be considered as individual investment advice or recommendations. Webull is not responsible or liable in any way for comments posted by pur users.


Share to:

Download the Webull App and join community for discussions about the post. Download

All Comments(1)

PushingBenjimins3305/05/2020 21:21
yes couldn't be told any better


Hot Article
$Twitter #twitterfucked is going down like Heels Up Harris does at a job interviewKOMKOR_PIKAGE 01/15/2021 16:22
$Bionano Genomics one day im gonna tell my grandkids about this stockMr Deeds 01/15/2021 14:49